JEC II Associates, LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-22 4:15 pm Sale | 2022-09-21 | 13D | Crescent Biopharma, Inc. CBIO | JEC II Associates, LLC | 0 0.000% | -6,351 (Position Closed) | Filing |
| 2022-08-01 4:15 pm Unchanged | 2022-07-31 | 13D | Crescent Biopharma, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 0 (Unchanged) | Filing |
| 2022-07-01 4:15 pm Unchanged | 2022-06-29 | 13D | Crescent Biopharma, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 0 (Unchanged) | Filing |
| 2022-06-21 5:02 pm Purchase | 2022-06-13 | 13D | Crescent Biopharma, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 6,351 (New Position) | Filing |